| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Geode Capital Management, L.L.C.
|
18.438k | 0.84% | +17.610k | Mar 31 2026 |
| 2 |
UBS Financial Services, Inc.
|
8.722k | 0.40% | +8.722k | Mar 31 2026 |
| 3 |
Intracoastal Capital, L.L.C.
|
8.191k | 0.37% | +8.191k | Dec 31 2025 |
| 4 |
Tower Research Capital LLC
|
1.060k | 0.05% | +958.000 | Mar 31 2026 |
| 5 |
BlackRock Institutional Trust Company, N.A.
|
7.000 | 0.00% | -1.000 | Mar 31 2026 |
|
1
Geode Capital Management, L.L.C.
|
0.84%
18.438k
|
|
2
UBS Financial Services, Inc.
|
0.40%
8.722k
|
|
3
Intracoastal Capital, L.L.C.
|
0.37%
8.191k
|
|
4
Tower Research Capital LLC
|
0.05%
1.060k
|
|
5
BlackRock Institutional Trust Company, N.A.
|
0.00%
7.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 1.66% of Vallon Pharmaceuticals Inc, with Geode Capital Management, L.L.C. the biggest at 0.84%, followed by UBS Financial Services, Inc. (0.40%) and Intracoastal Capital, L.L.C. (0.37%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Vallon Pharmaceuticals Inc has risen over the past 12 months from around 2.0% to 5.4% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


